Isolated nucleic acid duplex for reducing huntington gene expression

• US 7,902,352 B2
• Filed: 08/09/2006
• Issued: 03/08/2011
• Est. Priority Date: 05/06/2005
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Kaemmerer, William F., Kaytor, Michael D.
• Primary Examiner(s): ANGELL, JON E
• Application Number:
  US11/501,634
• Publication Number:
  US 20070261126A1
• Time in Patent Office: 1,672 Days
• Field of Search: 536/24.5, 514/44.A
• US Class Current: 536/24.5
• CPC Class Codes: A61P 25/14 for treating abnormal movements, e.g. chorea, dyskinesia
• CPC Class Codes: C12N 15/113 Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing when used in plants C12N15/8218
• CPC Class Codes: C12N 2310/111 spanning the whole gene, or a large part of it
• CPC Class Codes: C12N 2310/14 interfering N.A.
• CPC Class Codes: C12N 2750/14143 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2750/14171 Demonstrated in vivo effect

Abstract

Disclosed herein are sequences, molecules and methods used to suppress the expression of HD genes encoding for huntingtin protein in primates including Macaca mulatta and Homo sapiens. These sequences, molecules and methods aid in the study of the pathogenesis of HD and can also provide a treatment for this disease by reducing HD mRNA without causing death, locomotor impairment or cellular alterations of the Macaca mulatta and Homo sapiens.

Claims

1. An isolated nucleic acid duplex comprising a first strand of nucleic acid and a second strand of nucleic acid, wherein the first strand comprises at least 19 contiguous nucleotides encoded by SEQ ID NO:

4, wherein the second strand is complementary to at least 15 contiguous nucleotides within SEQ ID NO;

4 of the first strand, wherein said nucleic acid duplex functions to reduce the expression of the Huntington gene in a cell when administered to said cell and wherein the nucleic acid duplex is between 19 and 30 base pairs in length.

2. The nucleic acid duplex according to claim 1, wherein said first and/or said second strand further comprises an overhang region.

3. The nucleic acid duplex according to claim 2, wherein said overhang region comprises a 3′

overhang region, a 5′

overhang region, or both 3′ and

5′

overhang regions.

4. The nucleic acid duplex according to claim 2, wherein said overhang region is from 1 to 10 nucleotides in length.

5. The nucleic acid duplex according to claim 1, wherein said first strand and said second strand are operably linked by means of a nucleic acid loop strand to form a hairpin structure comprising a duplex structure and a loop structure.

6. The nucleic acid duplex according to claim 5, wherein said loop structure contains from 4 to 10 nucleotides.

7. An expression cassette comprising a nucleic acid sequence that encodes a sequence consisting of the first strand or second strand of the nucleic acid duplex of claim 1.

8. The expression cassette according to claim 7, further comprising a promoter.

9. The expression cassette according to claim 8, wherein said promoter is a regulatable promoter.

10. The expression cassette according to claim 8, wherein said promoter is a constitutive promoter.

11. The expression cassette according to claim 10, wherein said promoter is a CMV, RSV, pol II or pol III promoter.

12. The expression cassette according to claim 7, wherein said expression cassette further comprises a polyadenylation signal.

13. The expression cassette according to claim 12, wherein said polyadenylation signal is a synthetic minimal polyadenylation signal.

14. The expression cassette according to claim 7, further comprising a marker gene.

15. A vector comprising the expression cassette of claim 7.

16. A vector comprising two expression cassettes, wherein the first expression cassette comprises a nucleotide sequence that encodes a sequence consisting of the first strand of said nucleic acid duplex of claim 1 and the second expression cassette comprises a nucleotide sequence that encodes a sequence consisting of the second strand of the nucleic acid duplex of claim 1.

17. The vector of claim 16, wherein said vector is a viral vector.

18. The vector according to claim 17, wherein said vector is an adenoviral, lentiviral, adeno-associated viral (AAV), poliovirus, herpes simplex virus, feline immunodeficiency virus or murine Maloney-based viral vector.

19. The vector of claim 18, wherein the viral vector is the adeno-associated viral (AAV) vector.

20. The vector of claim 16, further comprising a promoter.

21. The vector of claim 20, wherein said promoter is an inducible promoter.

22. An isolated cell comprising the expression cassette of claim 7.

23. An isolated cell of claim 22, wherein said cell is a mammalian cell.